WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.


C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS

All plain beta blocking agents are classified in this group.
Labetalol, and carvedilol are classified in C07AG - Alpha- and beta blocking agents.
Beta blocking agents in combination with ACE inhibitors are classified in C09BX - ACE inhibitors, other combinations.
Beta blocking agents in combination with ARBs are classified in C09DX - Angiotensin II receptor blockers (ARBs), other combinations.

The DDDs are based on the treatment of mild-moderate hypertension.
The DDDs for oral and parenteral formulations are equal, even if the parenteral preparations are used for the initial treatment of arrhythmias. Exception: practolol.


C07AA Beta blocking agents, non-selective

All plain non-selective beta blocking agents are classified in this group.


    ATC code  Name  DDD  U Adm.R Note
    C07AA23 penbutolol 40 mg 

List of abbreviations

Last updated: 2024-01-26